MicroRNAs as Novel Biomarkers in Colorectal Cancer

MicroRNAs (miRNAs) play an important role in various physiologic and developmental processes and in the initiation and progression of cancer. This class of small, non-coding RNAs critically regulate gene expression at the post-transcriptional level and evidence suggests that they may function as both oncogenes and tumor suppressors. Colorectal cancer (CRC) is a major healthcare concern worldwide and in order to reduce CRC related deaths, research is aimed into the search for some novel screening approaches. In this sense, miRNAs are rapidly emerging as a novel class of biomarkers, with good potential as diagnostic and therapeutic targets. This review summarizes the recent findings of the clinicopathological relevance that miRNAs have in CRC initiation, development, and progress, highlighting their potential diagnostic, prognostic, and therapeutic use in CRC, focusing on the group of microsatellite instable and the group of hypermethylated CRCs, as well as discussing future prospects.

[1]  J. Hardcastle,et al.  Colorectal cancer , 1993, Europe Against Cancer European Commission Series for General Practitioners.

[2]  Y. Nakamura,et al.  [Colorectal cancers]. , 1997, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.

[3]  S N Thibodeau,et al.  Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. , 1998, Cancer research.

[4]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[5]  J. Herman,et al.  CpG island methylator phenotype in colorectal cancer. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[6]  C. Croce,et al.  Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[7]  Michael Z Michael,et al.  Reduced accumulation of specific microRNAs in colorectal neoplasia. , 2003, Molecular cancer research : MCR.

[8]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[9]  J. Castle,et al.  Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs , 2005, Nature.

[10]  S. Lowe,et al.  A microRNA polycistron as a potential human oncogene , 2005, Nature.

[11]  H. Horvitz,et al.  MicroRNA expression profiles classify human cancers , 2005, Nature.

[12]  X. Agirre,et al.  Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues , 2006, Molecular Cancer.

[13]  Y. Akao,et al.  MicroRNAs 143 and 145 are possible common onco-microRNAs in human cancers. , 2006, Oncology reports.

[14]  Y. Akao,et al.  let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. , 2006, Biological & pharmaceutical bulletin.

[15]  A. Williams,et al.  Functional aspects of animal microRNAs , 2008, Cellular and Molecular Life Sciences.

[16]  R. Vyzula,et al.  Altered Expression of miR-21, miR-31, miR-143 and miR-145 Is Related to Clinicopathologic Features of Colorectal Cancer , 2008, Oncology.

[17]  George A Calin,et al.  mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer , 2007, Molecular Cancer.

[18]  Minoru Toyota,et al.  Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer , 2007, Proceedings of the National Academy of Sciences.

[19]  Jan Gorodkin,et al.  Principles and limitations of computational microRNA gene and target finding. , 2007, DNA and cell biology.

[20]  D. Valle,et al.  DNA methylation regulates microRNA expression , 2007, Cancer biology & therapy.

[21]  B. Louis,et al.  Enjoy the Silence: The Story of let-7 MicroRNA and Cancer. , 2007, Current genomics.

[22]  T. Brabletz,et al.  A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells , 2008, EMBO reports.

[23]  T. Hibi,et al.  The role of microRNAs in gastrointestinal cancers , 2009, Journal of Gastroenterology.

[24]  Clara Nervi,et al.  MicroRNA: basic mechanisms and transcriptional regulatory networks for cell fate determination. , 2008, Cardiovascular research.

[25]  George A Calin,et al.  MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. , 2008, JAMA.

[26]  S. Ropero,et al.  A microRNA DNA methylation signature for human cancer metastasis , 2008, Proceedings of the National Academy of Sciences.

[27]  H. Allgayer,et al.  MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer , 2008, Oncogene.

[28]  G. Nuovo,et al.  Experimental validation of miRNA targets. , 2008, Methods.

[29]  X. Chen,et al.  Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases , 2008, Cell Research.

[30]  Frank J. Sørensen,et al.  Diagnostic and prognostic microRNAs in stage II colon cancer. , 2008, Cancer research.

[31]  M. Washington,et al.  Epigenetic silencing of the intronic microRNA hsa-miR-342 and its host gene EVL in colorectal cancer , 2008, Oncogene.

[32]  M. Toyota,et al.  Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. , 2008, Cancer research.

[33]  E. Ng,et al.  Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening , 2009, Gut.

[34]  X. Chen,et al.  Role of miR-143 targeting KRAS in colorectal tumorigenesis , 2009, Oncogene.

[35]  Jun Yu,et al.  MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer , 2009, British Journal of Cancer.

[36]  Xabier Agirre,et al.  Epigenetic regulation of microRNA expression in colorectal cancer , 2009, International journal of cancer.

[37]  G. Packham,et al.  MicroRNAs: key players in carcinogenesis and novel therapeutic targets. , 2009, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[38]  Zongguang Zhou,et al.  Clinicopathological Significance of microRNA-31, -143 and -145 Expression in Colorectal Cancer , 2009, Disease markers.

[39]  G. Tsongalis,et al.  MicroRNAs: novel biomarkers for human cancer. , 2009, Clinical chemistry.

[40]  K. Mimori,et al.  Over- and under-expressed microRNAs in human colorectal cancer. , 2009, International journal of oncology.

[41]  Marek Svoboda,et al.  MicroRNAs in colorectal cancer: translation of molecular biology into clinical application , 2009, Molecular Cancer.

[42]  C. Croce,et al.  Pathogenetic and clinical relevance of microRNAs in colorectal cancer. , 2009, Cancer genomics & proteomics.

[43]  Muller Fabbri,et al.  Modulation of mismatch repair and genomic stability by miR-155 , 2010, Proceedings of the National Academy of Sciences.

[44]  A. Bardelli,et al.  Association of KRAS p.G13D mutation with outcome in patients with chemotherapy-refractory metastatic colorectal cancer treated with cetuximab. , 2010, JAMA.

[45]  Zhaohui Huang,et al.  Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer , 2010, International journal of cancer.

[46]  D. Amadori,et al.  MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2) , 2010, Proceedings of the National Academy of Sciences.

[47]  C. Boland,et al.  Fecal MicroRNAs as Novel Biomarkers for Colon Cancer Screening , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[48]  B. Nordlinger,et al.  Colorectal cancer – Authors' reply , 2010, The Lancet.

[49]  Ronald Abraham,et al.  Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma. , 2010, The Journal of molecular diagnostics : JMD.

[50]  A. Choi,et al.  Identification and Functional Analysis of Epigenetically Silenced MicroRNAs in Colorectal Cancer Cells , 2011, PloS one.

[51]  Y. Asmann,et al.  miRNA Expression in Colon Polyps Provides Evidence for a Multihit Model of Colon Cancer , 2011, PloS one.

[52]  C. Boland,et al.  Colorectal Cancers with Microsatellite Instability Display Unique miRNA Profiles , 2011, Clinical Cancer Research.

[53]  M. Nykter,et al.  Circulating Plasma MiR-141 Is a Novel Biomarker for Metastatic Colon Cancer and Predicts Poor Prognosis , 2011, PloS one.

[54]  F. Roviello,et al.  Epigenetically silenced miR-34b/c as a novel faecal-based screening marker for colorectal cancer , 2011, British Journal of Cancer.

[55]  I. Nagtegaal,et al.  Beyond KRAS mutation status: influence of KRAS copy number status and microRNAs on clinical outcome to cetuximab in metastatic colorectal cancer patients , 2012, BMC Cancer.

[56]  R. Wolff,et al.  MicroRNAs and colon and rectal cancer: Differential expression by tumor location and subtype , 2011, Genes, chromosomes & cancer.

[57]  Jonathan M. Hernandez,et al.  Complementary Strand MicroRNAs Mediate Acquisition of Metastatic Potential in Colonic Adenocarcinoma , 2012, Journal of Gastrointestinal Surgery.

[58]  Hui Wang,et al.  MicroRNA-342 inhibits colorectal cancer cell proliferation and invasion by directly targeting DNA methyltransferase 1. , 2011, Carcinogenesis.

[59]  S. Gruber,et al.  Micromanaging the Classification of Colon Cancer: The Role of the microRNAome , 2011, Clinical Cancer Research.

[60]  Yanlei Ma,et al.  NIRF is frequently upregulated in colorectal cancer and its oncogenicity can be suppressed by let-7a microRNA. , 2012, Cancer letters.

[61]  T. Eberlein.  Association of KRAS p.G13D Mutation With Outcome in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer Treated With Cetuximab , 2012 .

[62]  J. Gu,et al.  Let‐7c functions as a metastasis suppressor by targeting MMP11 and PBX3 in colorectal cancer , 2012, The Journal of pathology.

[63]  E. Bandrés,et al.  MiRNAs and LincRNAs: Could They Be Considered as Biomarkers in Colorectal Cancer? , 2012, International journal of molecular sciences.

[64]  S. Rai,et al.  Plasma MiR-21: A Potential Diagnostic Marker of Colorectal Cancer , 2012, Annals of surgery.

[65]  M. Chen,et al.  miR-200c inhibits invasion and migration in human colon cancer cells SW480/620 by targeting ZEB1 , 2012, Clinical & Experimental Metastasis.